These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1693445)

  • 21. [Tumor markers in the diagnosis of lung cancer].
    Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
    Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
    Bellet D; Bidart JM
    Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ascitic fluid: benignancy and malignancy parameters].
    Fluixá Carrascosa F; Rull Segura S; Devesa Jorda F; Martín Estruch A; Tur Cotaina MD; Borghol Hariri A; Pérez Serra J
    Rev Esp Enferm Dig; 1996 Jan; 88(1):35-8. PubMed ID: 8615999
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor markers. Key pieces to your cancer patient's clinical picture.
    Ostchega Y; Culnane M
    Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
    Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
    Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality control in tumor marker values: methology, results and potential problems].
    Ben Ayed M; Ben Hadj Hmida Y; Kassis M; Damak J; Masmoudi H
    Tunis Med; 2001; 79(6-7):341-7. PubMed ID: 11771428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for heterogeneous enzyme immunoassays for tumor markers.
    King WJ; Tomita JT; Dowell BL; Delfert DM
    Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of tumor markers in the treatment of germ cell tumors].
    Germá Lluch JR; García del Muro X; Galán MC
    Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of tumor markers in pleural effusions].
    Botte G; Laferrere L; Etchepare S; Dalurzo D; Duhart JE; Adaro FV
    Medicina (B Aires); 1990; 50(3):213-6. PubMed ID: 2130207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor markers.
    Seleznick MJ
    Prim Care; 1992 Dec; 19(4):715-26. PubMed ID: 1281552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
    Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
    Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncofetal antigens in sacrococcygeal teratomas.
    Kuhajda FP; Taxy JB
    Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z
    Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.